Results 191 to 200 of about 114,734 (260)

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

BJU International, Volume 138, Issue 1, Page 125-132, July 2026.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort, Jørgen B. Jensen, Andreas Ernst   +2 more
wiley   +1 more source

Bladder calculi and ischemic bowel loop in association with inguinal sliding bladder hernia. [PDF]

J Surg Case Rep
Arabadzhiev A, Yordanov NY, Sokolov M, Kyumyurdzhiyski Y, Popov T.   +4 more
europepmc   +1 more source

A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer

BJU International, Volume 138, Issue 1, Page 144-155, July 2026.
Objectives To establish a UK consensus vision of a standardised genomic testing pathway in unresectable/metastatic urothelial cancer (mUC) with clear roles and responsibilities for multidisciplinary team (MDT) members and molecular pathology laboratory teams, and to agree how the pathway must evolve to accommodate emerging innovations.
Syed A. Hussain, Amarnath Challapalli, Simran Gill, Michael Hubank, Hannah Markham, Philippe Tanière, Simon Wyatt, Robert Jones   +7 more
wiley   +1 more source

Persistent follicular cystitis following intravesical gemcitabine: a case series and literature review. [PDF]

BMC Cancer
Wu Q, Lu P, Zhang X, Qing X, Gao W.
europepmc   +1 more source

Endosalpingiosis of Urinary Bladder Mimicking Bladder Neoplasm: A Case Report

Investigative Magnetic Resonance Imaging
Hyunyoung Bae, Hyuk Jung Kim, Suk Ki Jang, Eun Mee Han   +3 more
openaire   +1 more source

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes. [PDF]

World J Urol
Santarelli V, Asero V, Corvino R, De Berardinis E, Sciarra A, Basile G, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Grobet-Jeandin E, Reynard M, Mari A, Mertens LS, Soria F, Teoh J, Claps F, Amodeo A, Ślusarczyk A, Contieri R, Perdonà S, Subiela JD, Tully KH, Pichler R, Antonelli A, Bertolo R, Ditonno F, Hurle R, Crocetto F, Mayr R, Porreca A, Marino F, Simone G, Tuderti G, Rocco BMC, Sighinolfi C, Vittori L, Moschini M, Zaurito P, De Angelis M, Scillipoti P, Afferi L, De Groote R, De Naeyer G, Mottrie A, Pavan N, Chung BI, Marcq G, Pradere B, Del Giudice F, European Association of Urology -Young Academic Urologists (EAU -YAU), Urothelial Carcinoma Working Group.   +59 more
europepmc   +1 more source

The first United States prospective trial using the Hugo™ robot‐assisted surgery system

BJU International, Volume 138, Issue 1, Page 85-91, July 2026.
Objective To describe the safety and effectiveness of the Hugo™ robot‐assisted surgery (RAS) system (Medtronic, Minneapolis, MN, USA) when used for three urological procedures. Patients and Methods The Expand URO (ClinicalTrials.gov identifier: NCT05696444) was the first investigational study for the Hugo RAS system based in the United States. It was a
Michael R. Abern, Peter Wiklund, Alvin C. Goh, Jihad H. Kaouk, Simone Crivellaro, Clayton S. Lau, Ali A. Zhumkhawala, Rogerio Huang, Reza Mehrazin, John P. Sfakianos, Ikenna Madueke, Brant A. Inman, Casey Blaser, Michele Masters, James R. Porter   +14 more
wiley   +1 more source

Successfully Deflating a Stubborn Foley Catheter Balloon With Mineral Oil. [PDF]

Cureus
Reddy V, Thompson A.
europepmc   +1 more source

Immune Checkpoint Inhibitor-Induced Ureteritis and Cystitis in Patients With Lung Cancer and Uterine Malignancies: A Case Series and Literature Review. [PDF]

J Immunother
Yan Y, Dou Q, Wu X, Zhang X, Liu X, Si X, Zhang L.   +6 more
europepmc   +1 more source